Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Serial tumour markers serum carcinoembryonic antigen and cancer antigen 15-3 assays in detecting symptomatic metastasis in breast cancer patients.

Bahrami A, Mortazavizadeh MR, Yazdi MF, Chamani M.

East Mediterr Health J. 2012 Oct;18(10):1055-9.

PMID:
23301361
[PubMed - indexed for MEDLINE]
2.

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.

Nicolini A, Tartarelli G, Carpi A, Metelli MR, Ferrari P, Anselmi L, Conte M, Berti P, Miccoli P.

BMC Cancer. 2006 Nov 20;6:269.

PMID:
17116247
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).

Giovanella L, Ceriani L, Giardina G, Bardelli D, Tanzi F, Garancini S.

Clin Chem Lab Med. 2002 Mar;40(3):298-303.

PMID:
12005221
[PubMed - indexed for MEDLINE]
4.

Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.

Arslan N, Serdar M, Deveci S, Ozturk B, Narin Y, Ilgan S, Ozturk E, Ozguven MA.

Ann Nucl Med. 2000 Oct;14(5):395-9.

PMID:
11108173
[PubMed - indexed for MEDLINE]
5.

Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.

Kurebayashi J, Nomura T, Hirono M, Okubo S, Udagawa K, Shiiki S, Ikeda M, Nakashima K, Tanaka K, Sonoo H.

Jpn J Clin Oncol. 2006 Mar;36(3):150-3. Epub 2006 Mar 6.

PMID:
16520359
[PubMed - indexed for MEDLINE]
Free Article
6.

Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.

Samy N, Ragab HM, El Maksoud NA, Shaalan M.

Cancer Biomark. 2010;6(2):63-72. doi: 10.3233/CBM-2009-0119.

PMID:
20571232
[PubMed - indexed for MEDLINE]
7.

HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.

Zeiwar MM, Zaki SM, Mohammad LA, Zidan AA, El Nagar MR.

Egypt J Immunol. 2007;14(2):29-41.

PMID:
20306655
[PubMed - indexed for MEDLINE]
8.

Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.

Gion M, Peloso L, Mione R, Vignati G, Fortunato A, Saracchini S, Biasioli R, Gulisano M, Cappelli G.

Cancer J. 2001 May-Jun;7(3):181-90.

PMID:
11419026
[PubMed - indexed for MEDLINE]
9.

Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.

Daly L, Ferguson J, Cram GP Jr, Hars V, George SL, McCarty KS Jr, Bast RC Jr.

J Clin Oncol. 1992 Jul;10(7):1057-65.

PMID:
1607912
[PubMed - indexed for MEDLINE]
10.

Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.

Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.

Luminescence. 2000 Sep-Oct;15(5):283-9.

PMID:
11038485
[PubMed - indexed for MEDLINE]
11.

Comparison of serum CA15-3 and CEA in breast cancer.

Hou MF, Huang TJ, Hsieh JS, Huang YS, Huang CJ, Chan HM, Wang JY, Chen YL, Jong SB, Yang CC.

Gaoxiong Yi Xue Ke Xue Za Zhi. 1995 Dec;11(12):660-6.

PMID:
8551526
[PubMed - indexed for MEDLINE]
12.

Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer.

Hou MF, Chen YL, Tseng TF, Lin CM, Chen MS, Huang CJ, Huang YS, Hsieh JS, Huang TJ, Jong SB, Huang YF.

Kaohsiung J Med Sci. 1999 Sep;15(9):520-8.

PMID:
10561976
[PubMed - indexed for MEDLINE]
13.

Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.

El-Attar NI, Gaefar HA.

Egypt J Immunol. 2007;14(2):111-21.

PMID:
20306663
[PubMed - indexed for MEDLINE]
14.

Elevated serum CA15-3 levels correlate with positive estrogen receptor and initial favorable outcome in patients who died from recurrent breast cancer.

Nishimura R, Nagao K, Miyayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H.

Breast Cancer. 2003;10(3):220-7.

PMID:
12955034
[PubMed - indexed for MEDLINE]
15.

Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.

Nicolini A, Colombini C, Luciani L, Carpi A, Giuliani L.

Br J Cancer. 1991 Jul;64(1):154-8.

PMID:
1854615
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer.

Deprés-Brummer P, Itzhaki M, Bakker PJ, Hoek FJ, Veenhof KH, de Wit R.

J Cancer Res Clin Oncol. 1995;121(7):419-22.

PMID:
7635872
[PubMed - indexed for MEDLINE]
17.

The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.

Frenette PS, Thirlwell MP, Trudeau M, Thomson DM, Joseph L, Shuster JS.

Tumour Biol. 1994;15(5):247-54.

PMID:
7991985
[PubMed - indexed for MEDLINE]
18.

Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.

Heinze T, Schürenkämper P, Minguillon C, Lichtenegger W.

Anticancer Res. 1997 Jul-Aug;17(4B):2953-4.

PMID:
9329573
[PubMed - indexed for MEDLINE]
19.

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

Elfagieh M, Abdalla F, Gliwan A, Boder J, Nichols W, Buhmeida A.

Tumour Biol. 2012 Dec;33(6):2371-7. doi: 10.1007/s13277-012-0500-6. Epub 2012 Sep 5.

PMID:
22948780
[PubMed - indexed for MEDLINE]
20.

Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients.

Hu XC, Day W, Jones B, Loo WT, Chow LW.

Anticancer Res. 2002 May-Jun;22(3):1865-8.

PMID:
12168883
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk